Athena Countouriotis - May 20, 2025 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Director
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
May 20, 2025
Transactions value $
$0
Form type
4
Date filed
5/22/2025, 04:52 PM
Previous filing
Jun 13, 2024
Next filing
May 30, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Countouriotis Athena Director C/O BIOMARIN PHARMACEUTICAL INC., 770 LINDARO STREET, SAN RAFAEL /s/ Tae Sang Yoo, Attorney-in-Fact 2025-05-22 0001571469

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $0 +6.65K +96.38% $0.00 13.6K May 20, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units granted on May 20, 2025. Price not applicable.